The markets opened mixed with the Dow losing 17 points to 12,101 while Nasdaq rose 4 points to 2751 as investors monitored developments in Europe.
On the upside
Auxilium Pharmaceuticals (Nasdaq: AUXL) reported positive results from two late stage clinical trials of its Peyronie's disease treatment Xiaflex.
Galena Biopharma (Nasdaq: GALE) reported upbeat results from a Phase 1/2 clinical trial of its NeuVax vaccine.
Cleveland BioLabs (Nasdaq: CBLI) reported strong survival results from a Good Laboratory Practice efficacy study of its CBLB502.
On the downside
Roth Capital lowered its price target on Dendreon (Nasdaq: DNDN) from $12 to $6.70 saying that the biotechnology firm's prostate cancer treatment Provenge may lose market share.
Delta Air Lines (NYSE: DAL) reported a smaller than expected 6% gain in May passenger unit revenue.
A Seeking Alpha contributor listed MEMC Electronic Materials (NYSE: WFR) as the worst performing Russell 1000 stock in May.
In the broad market, declining issues outpaced advancers by a margin of nearly 5 to 4 on the NYSE while advancers edged out decliners by 9 to 7 on Nasdaq. The Russell 2000 which tracks small cap stocks added 2 points to 739.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here